Table 2.
Summary of various biosensors for HIV and HPV detection.
Platform | ECL luminophor | Type of Virus detection | ECL pathway | Linear ranges | LOD | Matrix | Ref |
---|---|---|---|---|---|---|---|
ECL | RGO@Au composite | HIV Immunosensor | coreactant | 10 ng mL−1 to 1 pg mL−1 |
1 ng mL−1 | serum samples | [64] |
ECL | Ti3C2Tx MXenes modified ZIF-8 | HIV aptasensor | coreactant | 1 nM 1 fM to |
0.3 fM | Serum sample | [65] |
ECL | CdSe QDs-DNA nano-network | HIV Genosensor | coreactant | 0.5 μM to 5 fM, | 2.4 fM | serum samples | [66] |
ECL | CdSe/ZnS quantum dots @poly(styrene/acrylamide) nanospheres | HIV Genosensor | coreactant | 50 nM to 0.5 pM | 39.81 fM | [67] | |
ECL | EuS NCs | HIV Genosensor | coreactant | 0.3 nM to 0.3 fM | 0.3 fM | Serum sample | [68] |
ECL | AuNCs | HPV Genosensor | coreactant | 0.1 fM to 10 nM | 0.06 fM | Clinical samples | [69] |
ECL | Ru(phen)32+ | HPV Genosensor | coreactant | 1 fM to 15 pM | 7.6 fM | Clinical samples | [70] |
ECL | AuNCs | HPV Genosensor | coreactant | 10 nM to 1pM | 0.48 pM | Blood sample | [71] |